effect of periodontal treatment on IL-17 and IL-23

Not Applicable

• Conditions: Condition 1: Chronic periodontitis. Condition 2: Aggressive periodontitis.; Chronic periodontitis; Aggressive periodontitis

• Registration Number: IRCT20180729040623N1
• Lead Sponsor: Shahed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 September 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

systematically healthy individuals with chronic or aggressive periodontitis

Exclusion Criteria

history of periodontal treatment within the previous six months, ,
use of any antibiotics /or immunosuppressive drugs in the past 3 months
consumption of any kind of medicine which affects periodontium (including medicine which cause gingival enlargement).
pregnancy
smoking
any immunosuppressive,metabolic or systemic disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin-17 level. Timepoint: before scaling and root-planning and 6 weeks after intervention. Method of measurement: ELISA test.;Interleukin-23 level. Timepoint: before scaling and root-planning and 6 weeks after intervention. Method of measurement: ELISA test.